<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04853537</url>
  </required_header>
  <id_info>
    <org_study_id>effect of IF on GD in obese</org_study_id>
    <nct_id>NCT04853537</nct_id>
  </id_info>
  <brief_title>Intermittent Fasting on the Incidence of Gestational Diabetes Mellitus Obese Pregnant Women in 3rd Trimester</brief_title>
  <official_title>Impact of Intermittent Fasting on the Incidence of Gestational Diabetes Mellitus(DM) in Obese Pregnant Women in 3rd Trimester</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled clinical trial will assess the impact of intermittent fasting on&#xD;
      the incidence of gestational DM in obese pregnant women in 3rd trimester and its effect on&#xD;
      maternal and neonatal outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The term intermittent fasting, when used for health reasons or weight loss, has been used to&#xD;
      describe various types of caloric restriction. Some authors use it when a patient withholds&#xD;
      caloric intake for several consecutive hours during the day (often 16 h with all energy&#xD;
      intake during the other 8 h of the day, others for a full day once or twice a week , and&#xD;
      others three or four days per week Some protocols allow protein intake but no carbohydrates&#xD;
      and still label it intermittent fasting.&#xD;
&#xD;
      Others allow carbohydrates or macro/micro-nutrients up to a limit that will still promote&#xD;
      ketosis and, although it is simply a low-calorie diet, due to the popularity of fasting this&#xD;
      has been labeled a diet that mimics fasting.&#xD;
&#xD;
      In this protocol we use 16hour fasting in 24hour with the same caloric intake in 8hour and&#xD;
      can drink water ,coffee , and other noncaloric beverages during the fast, which can help&#xD;
      reduce feelings of hunger .&#xD;
&#xD;
      In all instances, non-caloric fluid intake is permitted (which is one of the main differences&#xD;
      when compared to religious fasting) and therefore significantly reduces the risk of&#xD;
      dehydration and hypotension, a prominent consideration in religious fasting.&#xD;
&#xD;
      During the fasting hours and after breaking the fast, metabolic condition of the body could&#xD;
      be influenced as a consequence of change in the pattern and amount of activity, meals and&#xD;
      fluid intake, and even sleeping hours.&#xD;
&#xD;
      Intermittent fasting and low caloric intake have been shown to improve various metabolic and&#xD;
      inflammatory pathways. Insulin resistance, the most prominent feature of type 2 diabetes&#xD;
      during pregnancy, has long been known to improve with intermittent fasting. After a period of&#xD;
      fasting, insulin sensitivity rises and insulin levels fall. These result in improved fasting&#xD;
      and postprandial glucose levels. In addition, as insulin induces adipose tissue growth, there&#xD;
      is less propensity to weight gain and potentially even weight loss which leading to decrease&#xD;
      neonatal adverse effects of gestational DM and improved fetal outcome.&#xD;
&#xD;
      On the other hand, many other studies found that fasting has no effect on intrauterine&#xD;
      growth, birth weight, birth-time indices, gestational diabetes, preterm birth, and&#xD;
      preeclampsia. Predominantly, results of the studies examining the effects of fasting on&#xD;
      mothers and newborns are not homogenous; therefore, further research should be conducted to&#xD;
      attain valid findings.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>gestational diabetes</measure>
    <time_frame>from 24-36 weeks of gestation</time_frame>
    <description>percentage of diabetes in obese patient is increased by 1.3% and it will be assessed by glucose tolerance test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal weight gain,</measure>
    <time_frame>from 24-36 weeks of gestation</time_frame>
    <description>maternal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fetal weight</measure>
    <time_frame>on labour</time_frame>
    <description>fetal out come during delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fetal Apgar score</measure>
    <time_frame>on labour</time_frame>
    <description>score for baby after labour</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NICU(neonatal intensive care unit) admission</measure>
    <time_frame>on labour</time_frame>
    <description>fetal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mode of delivery</measure>
    <time_frame>on 36 weeks of gestation</time_frame>
    <description>NVD NVD(normal vaginal delivery) or C.S(caesarian section)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>any associated comorbidities questionnaires</measure>
    <time_frame>from 24-36 weeks of gestation</time_frame>
    <description>if there is other diseases developed like gestational hypertension</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">252</enrollment>
  <condition>Intermittent Fasting</condition>
  <condition>Gestational Diabetes</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>• 126 women will fast 16 consecutive hours per day including sleeping hours. and follow them from 26w till 36w by GTT(glucose tolerance test) and the weight gain and incidence of gestational diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>• 126 women will not fasting with the same life style and follow the incidence of gestational diabetes</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>intermittent fasting diet</intervention_name>
    <description>intermittent fasting diet to obese pregnant women &gt;30 BMI and incidence of gestational diabetes</description>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - 1. Healthy pregnant women. 2. Age (18 - 35 years old). 3. Women with BMI (_&gt; 30 kg/m2).&#xD;
&#xD;
        4. A living singleton pregnancy. Gestational age (24- 27 weeks).(recruitment time)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - 1. Multiple gestations. 2. Women with diabetes 3. pre-pregnancy cardiovascular disease,&#xD;
        chronic hypertensive, and pregnancy-induced hypertension; blood pressure _&gt; 140/90.&#xD;
&#xD;
        4. Women with hepatic, renal diseases or coagulopathy 5. Women with peptic ulcer.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>reda mokhtar, lecuterer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>aya abdelaziz, postgraduat</last_name>
    <phone>00201098859115</phone>
    <email>ayazizo93@gmail.com</email>
  </overall_contact>
  <reference>
    <citation>Alkandari JR, Maughan RJ, Roky R, Aziz AR, Karli U. The implications of Ramadan fasting for human health and well-being. J Sports Sci. 2012;30 Suppl 1:S9-19. doi: 10.1080/02640414.2012.698298. Epub 2012 Jun 29. Review.</citation>
    <PMID>22742901</PMID>
  </reference>
  <reference>
    <citation>Carter S, Clifton PM, Keogh JB. Effect of Intermittent Compared With Continuous Energy Restricted Diet on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Noninferiority Trial. JAMA Netw Open. 2018 Jul 6;1(3):e180756. doi: 10.1001/jamanetworkopen.2018.0756.</citation>
    <PMID>30646030</PMID>
  </reference>
  <reference>
    <citation>Corley BT, Carroll RW, Hall RM, Weatherall M, Parry-Strong A, Krebs JD. Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabet Med. 2018 May;35(5):588-594. doi: 10.1111/dme.13595. Epub 2018 Feb 27.</citation>
    <PMID>29405359</PMID>
  </reference>
  <reference>
    <citation>Furmli S, Elmasry R, Ramos M, Fung J. Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin. BMJ Case Rep. 2018 Oct 9;2018. pii: bcr-2017-221854. doi: 10.1136/bcr-2017-221854.</citation>
    <PMID>30301822</PMID>
  </reference>
  <reference>
    <citation>Grajower MM, Horne BD. Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus. Nutrients. 2019 Apr 18;11(4). pii: E873. doi: 10.3390/nu11040873.</citation>
    <PMID>31003482</PMID>
  </reference>
  <reference>
    <citation>Kim SY, England L, Wilson HG, Bish C, Satten GA, Dietz P. Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am J Public Health. 2010 Jun;100(6):1047-52. doi: 10.2105/AJPH.2009.172890. Epub 2010 Apr 15.</citation>
    <PMID>20395581</PMID>
  </reference>
  <reference>
    <citation>Harris L, Hamilton S, Azevedo LB, Olajide J, De Brún C, Waller G, Whittaker V, Sharp T, Lean M, Hankey C, Ells L. Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis. JBI Database System Rev Implement Rep. 2018 Feb;16(2):507-547. doi: 10.11124/JBISRIR-2016-003248.</citation>
    <PMID>29419624</PMID>
  </reference>
  <reference>
    <citation>Klempel MC, Kroeger CM, Bhutani S, Trepanowski JF, Varady KA. Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr J. 2012 Nov 21;11:98. doi: 10.1186/1475-2891-11-98.</citation>
    <PMID>23171320</PMID>
  </reference>
  <reference>
    <citation>Sakar MN, Gultekin H, Demir B, Bakir VL, Balsak D, Vuruskan E, Acar H, Yucel O, Yayla M. Ramadan fasting and pregnancy: implications for fetal development in summer season. J Perinat Med. 2015 May;43(3):319-23. doi: 10.1515/jpm-2013-0289.</citation>
    <PMID>24810552</PMID>
  </reference>
  <reference>
    <citation>Wei M, Brandhorst S, Shelehchi M, Mirzaei H, Cheng CW, Budniak J, Groshen S, Mack WJ, Guen E, Di Biase S, Cohen P, Morgan TE, Dorff T, Hong K, Michalsen A, Laviano A, Longo VD. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med. 2017 Feb 15;9(377). pii: eaai8700. doi: 10.1126/scitranslmed.aai8700.</citation>
    <PMID>28202779</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>July 18, 2021</last_update_submitted>
  <last_update_submitted_qc>July 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

